VDAC2 and hydrops fetalis: Reintroduction of VDAC2 in 6-week-old KO mice using an adeno-associated virus 9 (AAV9) vector seemed to partially rescue the cardiomyopathy phenotype suggesting a plausible role of VDAC2 as a therapeutic target in clinical HF.